Non-O blood type is the commonest genetic risk factor for VTE: Results from a meta-analysis of the literature

Seminars in Thrombosis and Hemostasis

Volumn 38, Issue 5, 2012, Pages 535-547

  Dentali, Francesco ^a   Sironi, Annapaola ^a   Ageno, Walter ^a   Turato, Sara ^a   Bonfanti, Carlo ^b   Frattini, Francesco ^b   Crestani, Silvia ^b   Franchini, Massimo ^b  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b C Pomao Hospital   (Italy)

Author keywords

ABO blood group; factor VIII; venous thromboembolism; von Willebrand factor

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN;

BLOOD DONOR; BLOOD GROUP ABO SYSTEM; CARDIOVASCULAR RISK; COMPUTER ASSISTED TOMOGRAPHY; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; EMBASE; GENETIC RISK; GENOTYPE; HUMAN; LUNG ANGIOGRAPHY; LUNG EMBOLISM; MEDICAL LITERATURE; MEDICAL SOCIETY; MEDLINE; MUTATIONAL ANALYSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; REVIEW; SYSTEMATIC REVIEW; THROMBOPHILIA; VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM; BLOOD; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS;

ABO BLOOD-GROUP SYSTEM; GENETIC PREDISPOSITION TO DISEASE; HUMANS; PROSPECTIVE STUDIES; VENOUS THROMBOEMBOLISM;

EID: 84872940852     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0032-1315758     Document Type: Review

References (55)

1. Lowe J. B. The blood group-specific human glycosyltransferases. Baillieres Clin Haematol: 1993; 6 2 465 492 (Pubitemid 23204999)
2. Preston A. E., Barr A. The plasma concentration of factor VIII in the normal population. Br J Haematol: 1964; 10 238 245
3. Franchini M., Capra F., Targher G., Montagnana M., Lippi G. Relationship between ABO blood group and von Willebrand factor levels: from biology to clinical implications. Thromb J: 2007; 5 14
4. Moeller A., Weippert-Kretschmer M., Prinz H., Kretschmer V. Influence of ABO blood groups on primary hemostasis. Transfusion: 2001; 41 1 56 60 (Pubitemid 32142246)
5. O'Donnell J. S., Laffan M. A. The relationship between ABO histo-blood group, factor VIII and von Willebrand factor. Transfus Med: 2001; 11 4 343 351 (Pubitemid 32771926)
6. Jenkins P. V., O'Donnell J. S. ABO blood group determines plasma von Willebrand factor levels: a biologic function after all? Transfusion: 2006; 46 10 1836 1844 (Pubitemid 44435738)
7. Gastineau D. A., Moore S. B. How important are ABO-related variations in coagulation factor levels? Transfusion: 2001; 41 1 4 5 (Pubitemid 32142237)
8. Favaloro E. J., Soltani S., McDonald J., Grezchnik E., Easton L., Favaloro J. WC. Reassessment of ABO blood group, sex, and age on laboratory parameters used to diagnose von Willebrand disorder: potential influence on the diagnosis vs the potential association with risk of thrombosis. Am J Clin Pathol: 2005; 124 6 910 917 (Pubitemid 41740192)
9. Gill J. C., Endres-Brooks J., Bauer P. J., Marks W. J. Jr, Montgomery R. R. The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood: 1987; 69 6 1691 1695 (Pubitemid 17091627)
10. Souto J. C., Almasy L., Muñiz-Diaz E., et al. Functional effects of the ABO locus polymorphism on plasma levels of von Willebrand factor, factor VIII, and activated partial thromboplastin time. Arterioscler Thromb Vasc Biol: 2000; 20 8 2024 2028 (Pubitemid 30644654)
11. Matsui T., Titani K., Mizuochi T. Structures of the asparagine-linked oligosaccharide chains of human von Willebrand factor. Occurrence of blood group A, B, and H(O) structures. J Biol Chem: 1992; 267 13 8723 8731
12. Sarode R., Goldstein J., Sussman I. I., Nagel R. L., Tsai H. M. Role of A and B blood group antigens in the expression of adhesive activity of von Willebrand factor. Br J Haematol: 2000; 109 4 857 864 (Pubitemid 30609769)
13. Sodetz J. M., Pizzo S. V., McKee P. A. Relationship of sialic acid to function and in vivo survival of human factor VIII/von Willebrand factor protein. J Biol Chem: 1977; 252 15 5538 5546 (Pubitemid 8167004)
14. Stroup D. F., Berlin J. A., Morton S. C., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA: 2000; 283 15 2008 2012 (Pubitemid 30214957)
15. McGinn T., Wyer P. C., Newman T. B., Keitz S., Leipzig R., For G. G.; Evidence-Based Medicine Teaching Tips Working Group. Tips for learners of evidence-based medicine: 3. Measures of observer variability (kappa statistic). CMAJ: 2004; 171 11 1369 1373 (Pubitemid 39573841)
16. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials: 1986; 7 3 177 188 (Pubitemid 17189972)
17. Higgins J. P., Thompson S. G., Deeks J. J., Altman D. G. Measuring inconsistency in meta-analyses. BMJ: 2003; 327 7414 557 560 (Pubitemid 37088507)
18. Sterne J. A., Egger M., Smith G. D. Systematic reviews in health care: investigating and dealing with publication and other biases in meta-analysis. BMJ: 2001; 323 7304 101 105 (Pubitemid 32681979)
19. Antoni G., Morange P. E., Luo Y., et al. A multi-stage multi-design strategy provides strong evidence that the BAI3 locus is associated with early-onset venous thromboembolism. J Thromb Haemost: 2010; 8 12 2671 2679
20. Kodama J., Seki N., Masahiro S., et al. D-dimer level as a risk factor for postoperative venous thromboembolism in Japanese women with gynecologic cancer. Ann Oncol: 2010; 21 8 1651 1656
21. Flinterman L. E., van Hylckama Vlieg A., Rosendaal F. R., Doggen C. J. Venous thrombosis of the upper extremity: effect of blood group and coagulation factor levels on risk. Br J Haematol: 2010; 149 1 118 123
22. Teixeira Mello T. B., Machado T. F., Montavão S. A., Ozello M. C., Annichino-Bizzacchi J. M. Assessing the coagulation factor levels, inherited thrombophilia, and ABO blood group on the risk for venous thrombosis among Brazilians. Clin Appl Thromb Hemost: 2009; 15 4 408 414
23. Lima M. B., de Oliveira-Filho A. B., Campos J. F., et al. Increased risk of venous thrombosis by AB alleles of the ABO blood group and Factor V Leiden in a Brazilian population. Genet Mol Biol: 2009; 32 2 264 267
24. Paiva S. G., Sabino A. P., Carvalho M. G., et al. Polymorphisms in exons 6 and 7 of the ABO locus and their association with venous thrombosis in young Brazilian patients. Blood Coagul Fibrinolysis: 2009; 20 2 122 128
25. Santos M. S., Guimraes D. AM, Paiva S. G., et al. ABO blood group genotyping and venous thrombosis in Brazilian women using estrogen. Journal of Thrombosis and Haemostasis. Conference: 22nd Congress of the International Society of Thrombosis and Haemostasis Boston, MA United States 2009
26. Adamczuk Y. P., Iglesias Varela M. L., Martinuzzo M. E., Cerrato G. S., Forastiero R. R. ABO blood group as a risk factor for venous thrombosis. Journal of Thrombosis and Haemostasis. Conference: 22nd Congress of the International Society of Thrombosis and Haemostasis Boston, MA United States 2009
27. Canonico M., Olié V., Carcaillon L., Tubert-Bitter P., Scarabin P. Y.; EStrogen and THromboEmbolism Risk (ESTHER) Study Group. Synergism between non-O blood group and oral estrogen in the risk of venous thromboembolism among postmenopausal women: The ESTHER study. Thromb Haemost: 2008; 99 1 246 248
28. Miñano A., Ordóñez A., España F., et al. AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms. Haematologica: 2008; 93 5 729 734 (Pubitemid 351669313)
29. Clark P., Walker I. D., Govan L., Wu O., Greer I. A. The GOAL study: a prospective examination of the impact of factor V Leiden and ABO(H) blood groups on haemorrhagic and thrombotic pregnancy outcomes. Br J Haematol: 2008; 140 2 236 240 (Pubitemid 350284489)
30. Ohira T., Cushman M., Tsai M. Y., et al. ABO blood group, other risk factors and incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE). J Thromb Haemost: 2007; 5 7 1455 1461 (Pubitemid 46965375)
31. Vormittag R., Bencur P., Ay C., et al. Low-density lipoprotein receptor-related protein 1 polymorphism 663 C > T affects clotting factor VIII activity and increases the risk of venous thromboembolism. J Thromb Haemost: 2007; 5 3 497 502 (Pubitemid 46680681)
32. Hiltunen L., Rautanen A., Rasi V., et al. An unfavorable combination of Factor V Leiden with age, weight, and blood group causes high risk of pregnancy-associated venous thrombosis: a population-based nested case-control study. Thromb Res: 2007; 119 4 423 432 (Pubitemid 46149887)
33. Procare-GEHT Group. ABO blood group but not haemostasis genetic polymorphisms significantly influence thrombotic risk: a study of 180 homozygotes for the Factor V Leiden mutation. Br J Haematol: 2006; 135 5 697 702
34. Tirado I., Mateo J., Soria J. M., et al. The ABO blood group genotype and factor VIII levels as independent risk factors for venous thromboembolism. Thromb Haemost: 2005; 93 3 468 474 (Pubitemid 40392534)
35. Larsen T. B., Johnsen S. P., Gislum M., Moller C. A., Larsen H., Sorensen H. T. ABO blood groups and risk of venous thromboembolism during pregnancy and the puerperium. A population-based, nested case-control study. J Thromb Haemost: 2005; 3 2 300 304 (Pubitemid 41623618)
36. Mercier B., Oger E., Le Gal G., Mottier D., Ferec C. Phenotypic but not allelic ABO blood group association with risk of venous thrombosis. Thromb Haemost: 2005; 93 2 388 389 (Pubitemid 40253751)
37. Morelli V. M., De Visser M. C., Vos H. L., Bertina R. M., Rosendaal F. R. ABO blood group genotypes and the risk of venous thrombosis: effect of factor V Leiden. J Thromb Haemost: 2005; 3 1 183 185 (Pubitemid 41647137)
38. Carter Y. M., Caps M. T., Meissner M. H. Deep venous thrombosis and ABO blood group are unrelated in trauma patients. J Trauma: 2002; 52 1 112 116 (Pubitemid 34094254)
39. Robert A., Aillaud M. F., Eschwège V., Randrianjohany A., Scarabin Y., Juhan-Vague I. ABO blood group and risk of venous thrombosis in heterozygous carriers of factor V Leiden. Thromb Haemost: 2000; 83 4 630 631 (Pubitemid 30201144)
40. González Ordóñez A. J., Medina Rodriguez J. M., Martín L., Alvarez V., Coto E. The O blood group protects against venous thromboembolism in individuals with the factor V Leiden but not the prothrombin (factor II G20210A) mutation. Blood Coagul Fibrinolysis: 1999; 10 5 303 307 (Pubitemid 29382672)
41. Wautrecht J. C., Galle C., Motte S., Dereume J. P., Dramaix M. The role of ABO blood groups in the incidence of deep vein thrombosis. Thromb Haemost: 1998; 79 3 688 689 (Pubitemid 28120810)
42. Nordström M., Lindblad B., Bergqvist D., Kjellström T. A prospective study of the incidence of deep-vein thrombosis within a defined urban population. J Intern Med: 1992; 232 2 155 160
43. Robinson W. M., Roisenberg I. Venous thromboembolism and ABO blood groups in a Brazilian population. Hum Genet: 1980; 55 1 129 131 (Pubitemid 10090203)
44. Jick H., Porter J. Thrombophlebitis of the lower extremities and ABO blood type. Arch Intern Med: 1978; 138 10 1566 1567 (Pubitemid 9257957)
45. Johnson R., Green J. R., Charnley J. Pulmonary embolism and its prophylaxis following the Charnley total hip replacement. Clin Orthop Relat Res: 1977; 127 127 123 132 (Pubitemid 8192266)
46. Talbot S., Wakley E. J., Langman M. J. A19 A29 B, and O blood-groups, Lewis blood-groups, and serum triglyceride and cholesterol concentrations in patients with venous thromboembolic disease. Lancet: 1972; 1 7761 1152 1154
47. Arthes F. G. An epidemiologic survey of hospitalized cases of venous thrombosis and pulmonary embolism in young women. Milbank Mem Fund Q: 1972; 50 Supp 2 233 243
48. Westerholm B., Wiechel B., Eklund G. Oral contraceptives, venous thromboembolic disease, and ABO blood type. Lancet: 1971; 2 7725 664
49. Talbot S., Wakley E. J., Ryrie D., Langman M. J. ABO blood-groups and venous thromboembolic disease. Lancet: 1970; 1 7659 1257 1259
50. Jick H., Slone D., Westerholm B., et al. Venous thromboembolic disease and ABO blood type. A cooperative study. Lancet: 1969; 1 7594 539 542
51. Dick W., Schneider W., Brockmueller K., Mayer W. Interrelations of thrombo-embolic diseases and blood group distribution. Thromb Diath Haemorrh: 1963; 143 472 474
52. Koster T., Blann A. D., Briët E., Vandenbroucke J. P., Rosendaal F. R. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet: 1995; 345 8943 152 155
53. Wu O., Bayoumi N., Vickers M. A., Clark P. ABO(H) blood groups and vascular disease: a systematic review and meta-analysis. J Thromb Haemost: 2008; 6 1 62 69
54. Rosendaal F. R., Reitsma P. H. Genetics of venous thrombosis. J Thromb Haemost: 2009; 7 01 301 304
55. TRégouët D. A., Heath S., Saut N., et al. Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach. Blood: 2009; 113 21 5298 5303